Anti-GDF8/Myostatin Antibody (Trevogrumab)
Catalog No.
F1709
Anti-GDF8/Myostatin Antibody (Trevogrumab)
Featured Products
Trevogrumab (REGN-1033) is a monoclonal antibody that targets GDF8 (growth differentiation factor 8, also known as myostatin). Trevogrumab is being studied in the treatment of sarcopenia, including disuse atrophy, chronic diseases, and changes in food and nutrient intake.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
1429201-24-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
SAR391786, REGN1033
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O14793
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
GDF8 / Myostatin
Please avoid freeze-thaw cycles.